| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(92)93288-X |
| P698 | PubMed publication ID | 1357300 |
| P50 | author | Cyril Desire Sylvain Mamotte | Q96047076 |
| P2093 | author name string | F. M. van Bockxmeer | |
| P433 | issue | 8824 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| homozygosity | Q114049690 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 879-880 | |
| P577 | publication date | 1992-10-01 | |
| 1992-10-10 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease | |
| P478 | volume | 340 |
| Q36317717 | A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality |
| Q35238574 | A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype |
| Q89763066 | APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study |
| Q40494272 | Alzheimer's Disease, ß-Amyloidosis, and Aging |
| Q72312865 | ApoE and ACE genes: impact on human longevity |
| Q37222426 | ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans |
| Q35238425 | Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex |
| Q34809332 | Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy. |
| Q33735872 | Apolipoprotein E gene polymorphism and dyslipidaemia in adult Asian Indians: A population based study from Calcutta, India |
| Q36493730 | Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease |
| Q36023835 | Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease |
| Q43546731 | Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study |
| Q73386919 | Apolipoprotein E genotype and coronary heart disease |
| Q77925896 | Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population |
| Q44433137 | Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia. |
| Q45128303 | Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects |
| Q53201984 | Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases. |
| Q36264522 | Apolipoprotein E4 polymorphism as risk factor for coronary heart disease among Indian subjects |
| Q36888352 | Apolipoprotein e4 allele and cognitive decline in elderly men. |
| Q72267742 | Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty |
| Q71264679 | Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease |
| Q28302842 | Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome |
| Q57337171 | Association of apolipoprotein (Apo)E genotype with plasma apo E levels |
| Q36888014 | Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study |
| Q79175758 | Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors |
| Q24811731 | Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. |
| Q53343192 | Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. |
| Q35631400 | Cholinesterase inhibitors and vascular dementia: another string to their bow? |
| Q36711327 | Common and rare gene variants affecting plasma LDL cholesterol |
| Q54430137 | Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study. |
| Q35874457 | Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports |
| Q73194210 | Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients |
| Q74581730 | Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey |
| Q74308758 | Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes |
| Q35881785 | Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. |
| Q40940199 | Genetic and aging epidemiology. The merging of two disciplines |
| Q48086269 | Genetic associations with human longevity at the APOE and ACE loci |
| Q28306136 | Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels |
| Q33860926 | Genetic risk factors and restenosis after percutaneous coronary interventions |
| Q30711968 | Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry |
| Q31033399 | Imaging studies and APOE genotype in persons at risk for Alzheimer's disease |
| Q35834286 | Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. |
| Q74333547 | Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? |
| Q36843011 | Molecular genetics of myocardial infarction |
| Q37250028 | Reduced memory in fat mass and obesity-associated allele carriers among older adults with cardiovascular disease |
| Q78176116 | Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease |
| Q34989464 | Similarities between Alzheimer's disease and vascular dementia |
| Q63440940 | Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease |
| Q33679098 | The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive |
| Q73098812 | The efficiency of genetic analysis of DNA from aged siblings to detect chromosomal regions implicated in longevity |
| Q53242907 | The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. |
| Q44844081 | The prevalence of the neuropathological lesions of Alzheimer's disease is independent of race and gender |
| Q48397866 | The relationship between apolipoprotein E, dementia, and vascular illness. |
| Q41695322 | The relationship between blood pressure and dementia: a review |
| Q35618918 | The role of cardiovascular risk factors in Alzheimer's disease |
| Q33950413 | The role of cerebral ischemia in Alzheimer's disease |
| Q41161234 | The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease. |
| Q33950366 | Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. |
Search more.